Background and Purpose: Cerebral vasoreactivity and collateral circulation are important protective mechanisms against cerebral ischemia. Previous studies suggest that the efficiency of these mechanisms can be reflected by extracranial arterial blood flow volume. Brain damage leading to neurological impairments can influence patients’ functional recovery after stroke. This study attempted to explore the potential value of poststroke extracranial arterial blood flow volume in the prediction of stroke patients’ functional outcome. Methods: We prospectively studied 362 consecutive patients who were hospitalized for recent acute strokes. All patients underwent extracranial arterial blood flow volume measurement of the carotid and vertebral arteries by color velocity imaging quantification within 3 days after admission. Their functional recovery was assessed 6 months after stroke. The effect of poststroke extracranial arterial blood flow volume on patients’ functional outcome was tested by multivariate ordinal regression after controlling for other independent variables. Significance was at p < 0.05. Results: Poststroke extracranial arterial blood flow volume together with age, prestroke modified Rankin scale, the National Institutes of Health Stroke Scale and diabetes mellitus had significant effects on the patients’ 6-month functional outcome as measured by the modified Rankin scale after controlling for other independent variables (p < 0.05). Conclusions: Poststroke extracranial arterial blood flow volume is an independent outcome predictor. The graded predictive power of this parameter is potentially more superior than other outcome predictors by allowing classification of stroke outcome according to the degree of severity. A large prospective study is thus warranted to investigate its clinical value in the management of stroke patients.

Keywords:
Ultrasonography, Blood flow, carotid arteries, Stroke
1.
Smith ME, Garraway WM, Smith DL, Akhtar AJ: Therapy impact on functional outcome in a controlled trial of stroke rehabilitation. Arch Phys Med Rehabil 1982;63:21–24.
2.
Kwakkel G, Wagenaar RC, Kollen BJ, Lankhorst GJ: Predicting disability in stroke – A critical review of the literature. Age Ageing 1997;25:479–489.
3.
Soloman BS, Gentry LA: Predictors in stroke outcome. Neurology 1997;48:1476–1477.
4.
De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P: A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke 1993;24:1178–1181.
5.
Baron JC: Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001;11(suppl 1):2–8.
6.
Fisher M: Clinical Atlas of Cerebrovascular Disorders. London, Mosby Year Book, 1994.
7.
Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E, Rossini PM, Caltagirone C, Silvestrini M: Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke 2001;32:1552–1558.
8.
Ho SS, Metreweli C, Yu CH: Colour velocity imaging quantification in the detection of intracranial collaterals. Stroke 2002;33:1795–1798.
9.
Ho SS, Lam WWM, Ng SCP, Lam MK, Chan MTV, Poon WS, Metreweli C: Cerebral vasoreactivity: a comparison of color velocity imaging quantification and stable xenon-enhanced CT. AJR 2005;184:948–952.
10.
Bamford J, Sandercock P, Dennsis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521–1526.
11.
Lall R, Campbell MJ, Walters SJ, Morgan K: A review of ordinal regression models applied on health-related quality of life assessments. Stat Methods Med Res 2002;11:49–67.
12.
Ho SS, Metreweli C: Preferred technique for blood flow volume measurement in cerebrovascular disease. Stroke 2000;31:1342–1345.
13.
Eicke MB, Tegeler CH: Ultrasonic quantification flow volumetry of the carotid arteries: initial experience with a color flow M-mode system. Cerebrovasc Dis 1995;5:145–149.
14.
Harrington K, Deane C, Campbell S: Measurement of volume flow with time domain and M-mode imaging: in vitro and in vivo validation studies. J Ultrasound Med 1996;15:715–720.
15.
Deane CR, Markus HS: Color velocity flow measurement: in vitro validation and application to human carotid arteries. Ultrasound Med Biol 1997;23:447–452.
16.
Ho SS, Chan YL, Yeung D, Metreweli C: Blood flow volume quantification of cerebral ischaemia: comparison of three non-invasive techniques of carotid and vertebral arteries. AJR 2002,178:551–556.
17.
Wong KS, for the Asian Acute Stroke Advisory Panel: Risk factors for early death in acute ischaemia stroke and intracerebral hemorrhage – A prospective hospital-based study in Asia. Stroke 1999;30:2326–2330.
18.
Sato A, Takahashi S, Soma Y, Ishii K, Kikuchi Y, Watanabe T, Sakamoto K: Cerebral infarction: early detection by means of contrast-enhanced cerebral arteries at MR imaging. Radiology 1991;178:433–439.
19.
Marks MP, Holmgren EB, Fox AJ, Patel S, von Kummer R, Froehlich J: Evaluation of early computed tomographic findings in acute ischemic stroke. Stroke 1999;30:389–392.
20.
Polak JF: Carotid ultrasound. Radiol Clin North Am 2001;39:569–589.
21.
Mihara F, Kuwabara Y, Yoshida T, Yoshiura T, Sasaki M, Masuda K, Matsushima T, Fukui M: Correlation between proton magnetic resonance spectroscopic lactate measurements and vascular reactivity in chronic occlusive cerebrovascular disease: a comparison with positron emission tomography. Magn Reson Imaging 2000;18:1167–1174.
22.
Kilpatrick MM, Yonas H, Goldstein S, Kassam AB, Gebel JM Jr, Wechsler LR, Jungreis CA, Fukui MB: CT-based assessment of acute stroke: CT, CT angiography, and xenon-enhanced CT cerebral blood flow. Stroke 2001;32:2543–2549.
23.
Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M: Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001;21:1472–1479.
24.
Pindzola RR, Balzer JR, Nemoto EM, Goldstein S, Yonas H: Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced CT cerebral blood flow and transcranial Doppler. Stroke 2001;32:1811–1817.
25.
Brooks WH, McClure RR, Jones MR, Coleman TC, Breathitt L: Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 2001;38:1589–1595.
26.
Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, Kay R: Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000;31:2641–2647.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.